Transient Myocardial Thickening in Cats Associated with Heart Failure

J Novo Matos1,2, N Pereira2, T Glaus2

  • 1Royal Veterinary College, University of London, Hatfield, UK.

Insights

Transient myocardial thickening (TMT) in cats is associated with a better prognosis than hypertrophic cardiomyopathy (HCM). Cats with TMT experienced resolution of congestive heart failure (CHF) and improved cardiac function, unlike those with persistent HCM.

Area of Science:

  • Veterinary Cardiology
  • Cardiovascular Diseases in Cats

Background:

  • Some cats with hypertrophic cardiomyopathy (HCM) and congestive heart failure (CHF) can experience resolution of both left ventricular hypertrophy and CHF.
  • Transient myocardial thickening (TMT) is a condition where cats present with thickened heart muscle that can resolve.

Purpose of the Study:

  • To characterize cats with TMT and CHF.
  • To compare the clinical features of cats with TMT and CHF to those with persistent HCM and CHF.

Main Methods:

  • A retrospective study analyzed clinical records from four veterinary centers.
  • Cats were categorized into TMT (initial left ventricular wall thickness [LVWT] ≥6 mm, resolving to <5.5 mm with CHF resolution) and HCM (persistent LVWT ≥6 mm) groups.
  • A total of 21 cats with TMT and 21 cats with HCM were included.

Main Results:

  • Cats with TMT were significantly younger (2 years) than those with HCM (8 years).
  • In TMT cats, LVWT normalized, and left atrium/aorta (LA/Ao) ratios decreased, with CHF recurrence in only 1 cat.
  • All TMT cats survived the study period, contrasting with a high mortality rate in HCM cats.

Conclusions:

  • Transient myocardial thickening occurs in younger cats, often following antecedent events.
  • The prognosis for cats with CHF associated with TMT is significantly better than for those with persistent HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
456
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
594
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
629
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
289